News
Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...
A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...
14h
Ansa on MSNItalo-US team in ALS diagnosis breakthrough
ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...
1d
HealthDay on MSNFDA approves ketamine product for surgical pain management
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
Retired industrial arts teacher Allen Mohr was said to have saved “a lot of kids from the scrap pile,” according to a former ...
The onset of motor neurone disease (MND) left Sarah without a voice and the use of her hands at the age of 34. It was within ...
Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results